148 related articles for article (PubMed ID: 1989150)
1. A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Kirkman RL; Shapiro ME; Carpenter CB; McKay DB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
Transplant Proc; 1991 Feb; 23(1 Pt 2):1066-7. PubMed ID: 1989150
[No Abstract] [Full Text] [Related]
2. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.
Cantarovich D; Giral M; Josien R; Karam G; Hourmant M; Dantal J; Blancho G; Soulillou JP
Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897
[No Abstract] [Full Text] [Related]
3. Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.
Reed MH; Shapiro ME; Strom TB; Carpenter CB; Letvin NL; Reimann K; Weinberg DS; Waldmann TA; Kirkman RL
Transplant Proc; 1989 Feb; 21(1 Pt 1):1028-30. PubMed ID: 2650064
[No Abstract] [Full Text] [Related]
4. A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients.
Hanto DW; Jendrisak MD; McCullough CS; So SK; Marsh JW; Rush T; Michalski S; Phelan D; Mohanakumar T
Transplant Proc; 1991 Feb; 23(1 Pt 2):1050-1. PubMed ID: 1899150
[No Abstract] [Full Text] [Related]
5. Renal transplantation with cyclosporine in the elderly population.
Velez RL; Brinker KR; Vergne-Marini PJ; Nesser DA; Long DL; Trevino G; Dickerman RM; Helfrich GB
Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
[No Abstract] [Full Text] [Related]
6. Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective randomized double-blind trial.
Waid TH; Lucas BA; Thompson JS; Munch LC; Brown S; Kryscio R; Prebeck R; VanHoy MA; Jezek D
Transplant Proc; 1991 Feb; 23(1 Pt 2):1062-5. PubMed ID: 1899152
[No Abstract] [Full Text] [Related]
7. Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
Mieny CJ; Nel PJ; Becker JH; Pretorius JP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1852. PubMed ID: 3079049
[No Abstract] [Full Text] [Related]
8. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
9. Is cyclosporine indicated in HLA-identical renal transplant recipients?
Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
[No Abstract] [Full Text] [Related]
10. Early experience with anti-Tac in clinical renal transplantation.
Kirkman RL; Shapiro ME; Carpenter CB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
Transplant Proc; 1989 Feb; 21(1 Pt 2):1766-8. PubMed ID: 2652578
[No Abstract] [Full Text] [Related]
11. Effective prevention of interstitial rejection crises in immunological high risk patients following renal transplantation: use of high doses of the new monoclonal antibody BMA 031.
Dendorfer U; Hillebrand G; Kasper C; Smely S; Weschka M; Hammer C; Racenberg J; Gurland HJ; Land W
Transplant Proc; 1990 Aug; 22(4):1789-90. PubMed ID: 2389450
[No Abstract] [Full Text] [Related]
12. Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapy.
Neuhaus P; Bechstein WO; Blumhardt G; Steffen R; Keck H; Lemmens P; Langrehr JM; Schlag H
Transplant Proc; 1993 Apr; 25(2):1940-1. PubMed ID: 8470234
[No Abstract] [Full Text] [Related]
13. The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients.
Chiu A; Landsberg D; Cameron EC; Manson AD; Shackleton C
Transplant Proc; 1991 Feb; 23(1 Pt 2):1039-40. PubMed ID: 1899146
[No Abstract] [Full Text] [Related]
14. Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation.
Carpenter CB; Kirkman RL; Shapiro ME; Milford EL; Tiney NL; Waldmann TA; Zimmerman CE; Ramos EL; Strom TB
Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):54-7. PubMed ID: 2683758
[TBL] [Abstract][Full Text] [Related]
15. Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
[No Abstract] [Full Text] [Related]
16. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
Carl S; Wiesel M; Daniel V; Staehler G
Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
[No Abstract] [Full Text] [Related]
17. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
Shield CF
Clin Transpl; 1990; ():265-74. PubMed ID: 2129408
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
19. Transfusion effect still present with quadruple immunosuppression in recipients of renal transplants.
Yang HC; Weaver AS; Gifford RR
Transplant Proc; 1991 Feb; 23(1 Pt 2):1247-8. PubMed ID: 1899159
[No Abstract] [Full Text] [Related]
20. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
Blümke M; Kirste G; Wanner U; Wilms H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
